These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A. Bidlingmaier C, Kurnik K, Escuriola-Ettingshausen C, Jager R, Klamroth R, Male C, Marosi A, Nemes L, von Stackelberg A, Kreuz W. Haemophilia; 2011 Sep; 17(5):e837-40. PubMed ID: 21649797 [No Abstract] [Full Text] [Related]
3. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response. Gringeri A, Musso R, Mazzucconi MG, Piseddu G, Schiavoni M, Pignoloni P, Mannucci PM, RITS-FITNHES Study Group. Haemophilia; 2007 Jul; 13(4):373-9. PubMed ID: 17610550 [Abstract] [Full Text] [Related]
4. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors. Orsini F, Rotschild C, Beurrier P, Faradji A, Goudemand J, Polack B. Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861 [Abstract] [Full Text] [Related]
5. Successful immune tolerance induction with factor VIII/von Willebrand factor concentrate in an elderly patient with severe haemophilia A and a high responder inhibitor. Rivolta GF, Di Perna C, Franchini M, Riccardi F, Ippolito L, Lombardi M, Tagliaferri A. Blood Transfus; 2010 Jan; 8(1):66-8. PubMed ID: 20104281 [No Abstract] [Full Text] [Related]
6. Novel therapies for immune tolerance in haemophilia A. Collins PW. Haemophilia; 2006 Dec; 12 Suppl 6():94-100; discussion 100-1. PubMed ID: 17123401 [Abstract] [Full Text] [Related]
8. von Willebrand factor: what is its role in the immune response in haemophilia? Kaveri S, Mannucci PM, Kurth MH, Ewing N, Kessler CM, Nugent DJ, Gomperts ED. Haemophilia; 2011 Jan; 17(1):e235-8. PubMed ID: 20546026 [No Abstract] [Full Text] [Related]
9. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study. Kreuz W, Escuriola Ettingshausen C, Vdovin V, Zozulya N, Plyushch O, Svirin P, Andreeva T, Bubanská E, Campos M, Benedik-Dolničar M, Jiménez-Yuste V, Kitanovski L, Klukowska A, Momot A, Osmulskaya N, Prieto M, Šalek SZ, Velasco F, Pavlova A, Oldenburg J, Knaub S, Jansen M, Belyanskaya L, Walter O, ObsITI study group, ObsITI committee. Haemophilia; 2016 Jan; 22(1):87-95. PubMed ID: 26202305 [Abstract] [Full Text] [Related]
11. Domain specificity of factor VIII inhibitors during immune tolerance induction in patients with haemophilia A. van Helden PM, Kaijen PH, Mauser-Bunschoten EP, Fischer K, van den Berg HM, Voorberg J. Haemophilia; 2010 Nov; 16(6):892-901. PubMed ID: 20491952 [Abstract] [Full Text] [Related]
14. Inhibitors in haemophilia A: the role of VWF/FVIII concentrates--a meeting report. Kaveri S, Gringeri A, Heisel-Kurth M, Kreuz W. Haemophilia; 2009 Mar; 15(2):587-91. PubMed ID: 19347997 [No Abstract] [Full Text] [Related]
18. The role of VWF for the success of immune tolerance induction. Kreuz W. Thromb Res; 2008 Jul; 122 Suppl 2():S7-S12. PubMed ID: 18549910 [Abstract] [Full Text] [Related]
19. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors. Reipert BM, van Helden PM, Schwarz HP, Hausl C. Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196 [Abstract] [Full Text] [Related]